BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5702669)

  • 1. [Personal modifications of the treatment of psoriasis by Goeckerman's method].
    Grupper C; Bourgeois-Spinasse J; Hincky M; Arouète J; Girard P
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(5):585-91. PubMed ID: 5702669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of psoriasis by Goeckerman's method modified at the Rothschild Foundation (coal tar + UV + psoralens)].
    Grupper C; Eisenmann D; Durepaire R; Bourgeois-Spinasse J; Edelson Y; Beretti B
    Ann Dermatol Syphiligr (Paris); 1976; 103(5-6):629-38. PubMed ID: 827969
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy.
    Andrys C; Borska L; Pohl D; Fiala Z; Hamakova K; Krejsek J
    Arch Dermatol Res; 2007 Mar; 298(10):479-83. PubMed ID: 17221216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum level of sCD30 molecule but not sCD30L in patients with psoriasis is reduced by Goeckerman's therapy.
    Ctirad A; Jan K; Lenka B; Zdenek F; Kveta H; Michal B; Karel E
    Int J Dermatol; 2011 Aug; 50(8):1033-5. PubMed ID: 21781086
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of long-wave ultraviolet light in Goeckerman treatment.
    Marsico AR; Eaglstein WH
    Arch Dermatol; 1973 Jul; 108(1):48-9. PubMed ID: 4716741
    [No Abstract]   [Full Text] [Related]  

  • 6. Goeckerman's therapy for psoriasis with special reference to serum pentraxin 3 level.
    Ctirad A; Lenka B; David P; Zdenek F; Kveta H; Karel E; Jan K
    Int J Dermatol; 2008 Oct; 47(10):1011-4. PubMed ID: 18986345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible genotoxic risk of combined exposure to pharmaceutical coal tar and UV-B radiation.
    Borská L; Fiala Z; Smejkalová J; Hamáková K; Kremlácek J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S14-5. PubMed ID: 15141964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Goeckerman treatment of psoriasis.
    Perry HO; Soderstrom CW; Schulze RW
    Arch Dermatol; 1968 Aug; 98(2):178-82. PubMed ID: 5667232
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genotoxic risk of Goeckerman's therapy of psoriasis. Pilot study--children].
    Borská L; Fiala Z; Smejkalová J; Hamáková K; Kremlácek J
    Acta Medica (Hradec Kralove) Suppl; 2004; 47(1):19-21. PubMed ID: 15745054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC and CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman's therapy.
    Pohl D; Andrýs C; Borská L; Fiala Z; Hamáková K; Ettler K; Krejsek J
    Acta Medica (Hradec Kralove); 2009; 52(1):9-13. PubMed ID: 19754001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of psoriasis with UV-light, tar and psoralens].
    Fischer T; Juhlin L
    Lakartidningen; 1975 Nov; 72(46):4511-4. PubMed ID: 1195911
    [No Abstract]   [Full Text] [Related]  

  • 12. Ambulatory Goeckerman treatment of psoriasis: experience with 200 patients.
    DesGroseilliers JP; Cullen AE; Rouleau GA
    Can Med Assoc J; 1981 Apr; 124(8):1018-20. PubMed ID: 7260786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.
    Pittelkow MR; Perry HO; Muller SA; Maughan WZ; O'Brien PC
    Arch Dermatol; 1981 Aug; 117(8):465-8. PubMed ID: 7259240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the importance of the Goekerman treatment in psoriasis. (Preliminary note)].
    Témime P; Oddoze L; Marchand JP
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(5):607-9. PubMed ID: 5587898
    [No Abstract]   [Full Text] [Related]  

  • 15. Ultraviolet light and tar in the Goeckerman treatment of psoriasis.
    Marsico AR; Eaglstein WH; Weinstein GD
    Arch Dermatol; 1976 Sep; 112(9):1249-50. PubMed ID: 793524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience of psoriasis treatment with Goeckerman's method (author's transl)].
    Koudelková V; Jelínková R; Danda J; Rozsívalová V
    Cesk Dermatol; 1981 Apr; 56(2):115-8. PubMed ID: 7237595
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum level of a soluble form of endoglin (CD105) is decreased after Goeckerman's therapy of psoriasis.
    Pohl D; Andrýs C; Borská L; Fiala Z; Hamaková K; Ettler K; Krejsek J
    Acta Medica (Hradec Kralove); 2011; 54(2):59-62. PubMed ID: 21842718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected immunological changes in patients with Goeckerman's therapy TNF-alpha, sE-selectin, sP-selectin, sICAM-1 and IL-8.
    Borská L; Fiala Z; Krejsek J; Andrýs C; Vokurková D; Hamáková K; Kremlácek J; Ettler K
    Physiol Res; 2006; 55(6):699-706. PubMed ID: 16497101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goeckerman treatment for remission of psoriasis refractory to biologic therapy.
    Serrao R; Davis MD
    J Am Acad Dermatol; 2009 Feb; 60(2):348-9. PubMed ID: 19150284
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of psoriasis.
    North C; Weinstein GD
    Am J Nurs; 1976 Mar; 76(3):410-2. PubMed ID: 1044490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.